Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca

Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。